Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Vancomycin Powder for Preventing Pediatric VP Shunt Infections
NCT07547826Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- May 2026
- Primary completion
- May 2027
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in ventriculoperitoneal shunt infection (VPSI), sponsored by Assiut University. Planned start May 2026; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
ventriculoperitoneal shunt infection (VPSI)
Beyond the preview
Go deeper on NCT07547826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07547826.